Health
Discoverey of four SARS-CoV-2 Mpro inhibitors, boceprevir, calpain inhibitors II and XII and GC-376 – News-Medical.Net
A team of scientists from the United States has recently revealed that small molecule inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
A team of scientists from the United States has recently revealed that small molecule inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease exhibit potent antiviral activity. These inhibitors show better efficacy when used in combination with antiviral medicine Remdesivir. The study is currently available on the bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19) pandemic,…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News22 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General22 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General22 hours agoWhy do states and territories have different school holidays?